Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in acute lymphoblastic leukemia.

Tim R Randolph1

  • 1Department of Clinical Laboratory Science, Doisy School of Allied Health Professions, Saint Louis University Health Sciences Center, St Louis, MO 63104-1111, USA. Randoltr@slu.edu

Clinical Laboratory Science : Journal of the American Society for Medical Technology
|November 24, 2004
PubMed
Summary

This study reviews Acute Lymphoblastic Leukemia (ALL) treatment, highlighting individualized plans and targeted therapies. Future advances will focus on designer drugs for specific molecular abnormalities in ALL.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing Falling Drop Hemoglobin Method by Comparing Capillary Versus Venous Blood and Determining the Stability of the Copper Sulfate Solution.

Journal of hematology·2024
Same author

A method of HbF determination for potential use in underdeveloped countries.

Clinical laboratory science : journal of the American Society for Medical Technology·2013
Same author

Novel test method (sickle confirm) to differentiate sickle cell anemia from sickle cell trait for potential use in developing countries.

Clinical laboratory science : journal of the American Society for Medical Technology·2012
Same author

Estimated prevalence of sickle cell in northern Haiti.

Clinical laboratory science : journal of the American Society for Medical Technology·2010
Same author

Pathophysiology of compound heterozygotes involving hemoglobinopathies and thalassemias.

Clinical laboratory science : journal of the American Society for Medical Technology·2009
Same author

Development of a micro-ESR system with potential for in-home use.

Clinical laboratory science : journal of the American Society for Medical Technology·2007

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Acute lymphoblastic leukemia (ALL) is a stem cell disorder causing lymphoblast overproduction.
  • Symptoms include fatigue, bleeding, and infections due to suppressed normal hematopoiesis.
  • ALL primarily affects children and responds better to chemotherapy than AML.

Purpose of the Study:

  • To review current treatment strategies for ALL.
  • To explore modifications for individualized patient care.
  • To identify novel therapeutic targets for ALL treatment.

Main Methods:

  • Review of current literature on ALL.
  • Analysis of individualized treatment modifications based on patient characteristics.
  • Identification of leukemogenic mechanisms and protein targets.

Related Experiment Videos

Main Results:

  • ALL exhibits high remission rates, with many patients achieving sustained remission.
  • Individualized treatment plans minimize toxicity and maximize response.
  • Cytogenetic, molecular, and microarray analyses have improved ALL classification and identified therapeutic targets.

Conclusions:

  • Prognostic indicators are improving ALL therapeutic planning and outcome prediction.
  • Individualized regimens minimize adverse events and maximize patient response.
  • Future ALL treatment will likely involve designer therapies targeting specific molecular abnormalities.